投稿日時:12/02/09 11:40 視聴回数:390回
カテゴリ:
ビジネス全般
タグ:
acetylcysteine 
acetaminophen 
Cumberland 
Globecomm 
Exelixis 
GCOM 
EXEL 
CPIX 
Nasdaq:CPIX 
Nasdaq:EXEL 
Nasdaq:GCOM 
クリエイティブ・コモンズ・ライセンス:
表示-改変禁止 2.1 日本
On its Second Quarter Fiscal 2012, Globecomm Systems Inc - GCOM - posted revenue of $95.2 million, a 35.5% increase year over year. Exelixis Inc - EXEL - reported results for the fourth quarter 2011, posting revenues of $93.3 million, compared to $40.8 million for the comparable period in 2010. Cumberland Pharmaceuticals Inc - CPIX - reported that it has received a Notice of Allowance from the United States Patent and Trademark Office relating to its new formulation of Acetadote (acetylcysteine) Injection, which is used to treat acetaminophen poisoning.
*********************
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! (Read Full Disclaimer at http://crwenewswire.com/disclaimer).